Process areas for improvement ID'd in early prostate cancer

August 22, 2012
Process areas for improvement ID'd in early prostate cancer
For men with early prostate cancer undergoing expectant management, compliance with RAND structural indicators is high, but there is considerable variability in compliance with process indicators, according to a study published in the September issue of The Journal of Urology.

(HealthDay) -- For men with early prostate cancer undergoing expectant management, compliance with RAND structural indicators is high, but there is considerable variability in compliance with process indicators, according to a study published in the September issue of The Journal of Urology.

Jamie Ritchey, M.P.H., from the American College of Surgeons in Chicago, and colleagues abstracted medical records data and measured compliance with the RAND-developed quality indicators (structure and process). Data were reviewed for 13,876 men with early-stage prostate cancer undergoing expectant management in 2000 to 2001.

The researchers found that there was high compliance with structural indicators (greater than 80 percent), while compliance with process indicators varied (19 to 87 percent). Differences in process indicators were seen for models based on hospital type and , but not for age, race, or .

"Using the RAND quality indicators, this study revealed several process areas for quality improvement among men with early-stage prostate cancer on expectant management in the United States," the authors write. "Efforts to improve the quality of early-stage care need to move beyond the paradigm of age, race, and insurance status."

One author disclosed financial ties to diagnostics manufacturers.

Explore further: Excess body weight associated with increased risk for prostate cancer recurrence

More information: Abstract
Full Text
Editorial (subscription or payment may be required)

Related Stories

Recommended for you

A new weapon for the war on cancer

June 28, 2017

Cancerous tumors are formidable enemies, recruiting blood vessels to aid their voracious growth, damaging nearby tissues, and deploying numerous strategies to evade the body's defense systems. But even more malicious are ...

The gene behind follicular lymphoma

June 28, 2017

Follicular lymphoma is an incurable cancer that affects over 200,000 people worldwide every year. A form of non-Hodgkin lymphoma, follicular lymphoma develops when the body starts making abnormal B-cells, which are white ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.